Ad-hoc announcement in compliance with Art. 17 MAR

euromicron AG is adjusting its forecast for fiscal year 2019 as a whole. According to preliminary figures, euromicron generated consolidated sales of EUR 221.9 million in the first nine months of fiscal year 2019, a decline of EUR 11.1 million compared to the previous year (previous year: EUR 233.0 million).

Despite lower sales, EBITDA (before IFRS 16) amounted to EUR 2.0 million, EUR 0.4 million higher than in the previous year (previous year: EUR 1.6 million). The EBITDA margin (before IFRS 16) was thus 0.9% (previous year: 0.7%). Working capital (after factoring) totaled EUR 40.1 million as of September 30, 2019 (previous year: EUR 43.4 million), so that at 13.1% a slightly better working capital ratio (after factoring) was achieved (previous year: 13.5%).

Overall, business at several of the euromicron Group’s operating companies fell short of expectations. Order postponements could not be offset by the positive developments at other companies. Against this backdrop, the Executive Board of euromicron AG now expects consolidated sales for fiscal year 2019 to range from EUR 310 million to EUR 325 million. In addition, the Executive Board now expects an EBITDA margin of between 2.0% and 4.5% for 2019. euromicron had originally forecast consolidated sales of between EUR 325 million and EUR 345 million and an EBITDA margin of between 4.0% and 5.5% for fiscal year 2019.

euromicron will publish the complete final results for the first nine months of 2019 on November 7, 2019.